← The Wire
GHNasdaq
Guardant Health, Inc.
Services-Medical Laboratories · DE · CIK 1576280
Guardant Health provides advanced blood and tissue tests, data, and AI analytics for precision oncology
red 8-K · 90d⚡ Elevated coverage
$17.45B
Market cap
$153.74
Last close
+3.0%
1D
+19.3%
5D
2.7M
Volume
Price · last 39 sessions+68.6%
May 4L $89.52 · H $153.74Jun 29
151
Total filings
Jun 18, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 18, 202610-Q10-QMay 7, 20268-KResults of OperationsMay 7, 2026DEFA14ADEFA14AApr 28, 2026DEF 14ADEF 14AApr 28, 20268-KExecutive ChangeApr 27, 202610-K10-KFeb 19, 20268-KResults of OperationsFeb 19, 20268-KResults of Operations · Reg FD DisclosureJan 12, 20268-KMaterial Agreement · New Debt / ObligationNov 7, 2025424B5424B5Nov 6, 2025424B5424B5Nov 4, 202510-Q10-QOct 29, 20258-KResults of OperationsOct 29, 20258-KReg FD DisclosureSep 24, 20258-KExecutive ChangeSep 15, 202510-Q10-QJul 30, 20258-KResults of OperationsJul 30, 20258-KShareholder VoteJun 20, 202510-Q10-QApr 30, 20258-KResults of OperationsApr 30, 2025DEFA14ADEFA14AApr 29, 2025DEF 14ADEF 14AApr 29, 20258-KMaterial Agreement · New Debt / ObligationApr 9, 202510-K10-KFeb 20, 20258-KResults of OperationsFeb 20, 20258-KMaterial Agreement · New Debt / ObligationFeb 14, 20258-KMaterial Agreement · Equity IssuanceFeb 7, 20258-KResults of Operations · Reg FD DisclosureJan 13, 2025SC 13GSC 13GNov 13, 2024SC 13GSEC SCHEDULE 13GNov 8, 202410-Q10-QNov 6, 20248-KResults of OperationsNov 6, 20248-KExecutive ChangeOct 24, 2024SC 13GSC 13GOct 7, 20248-KMaterial AgreementAug 23, 2024424B5424B5Aug 23, 202410-Q10-QAug 7, 20248-KResults of OperationsAug 7, 20248-KCompany UpdateJul 29, 20248-KExecutive ChangeJul 18, 20248-KShareholder VoteJun 14, 20248-KExecutive ChangeMay 31, 20248-KCompany UpdateMay 24, 202410-Q10-QMay 9, 20248-KResults of OperationsMay 9, 2024DEFA14ADEFA14AApr 25, 2024DEF 14ADEF 14AApr 25, 2024SC 13GSC 13GApr 12, 20248-KExecutive ChangeMar 22, 202410-K10-KFeb 22, 20248-KResults of OperationsFeb 22, 20248-KExecutive ChangeFeb 1, 2024SC 13GSC 13GJan 29, 20248-KResults of Operations · Reg FD DisclosureJan 8, 20248-KMaterial Agreement · Company UpdateDec 21, 2023424B5424B5Dec 21, 20238-KCompany UpdateDec 19, 20238-KCompany UpdateNov 15, 202310-Q10-QNov 6, 20238-KResults of OperationsNov 6, 20238-KExecutive ChangeNov 3, 20238-KReg FD DisclosureSep 7, 202310-Q10-QAug 3, 20238-KResults of OperationsAug 3, 20238-KCompany UpdateAug 1, 20238-KShareholder VoteJun 20, 20238-KCompany UpdateMay 25, 2023424B5424B5May 24, 2023424B5424B5May 22, 202310-Q10-QMay 9, 20238-KResults of OperationsMay 9, 20238-KReg FD DisclosureMay 9, 20238-KExecutive ChangeMay 8, 2023DEFA14ADEFA14AApr 27, 2023DEF 14ADEF 14AApr 27, 20238-KAuditor ChangeApr 10, 20238-KReg FD DisclosureMar 13, 20238-KExecutive ChangeFeb 27, 202310-K10-KFeb 23, 2023
Insider Activity
In the 90 days to Mar 18, 2026: 5 sold $6.3M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 18, 2026 | Tariq MusaDirector | Sell | 348 | $88.09 | $31K |
| Mar 16, 2026 | Bell Michael BrianChief Financial Officer | Sell | 3,000 | $87.04 | $261K |
| Mar 6, 2026 | Hidalgo Medina ManuelDirector | Sell | 1,000 | $91.61 | $92K |
| Mar 6, 2026 | Hidalgo Medina ManuelDirector | Sell | 300 | $91.30 | $27K |
| Mar 4, 2026 | Kalia KumudChief Information Officer | Sell | 26,980 | $95.12 | $2.6M |
| Mar 4, 2026 | Kalia KumudChief Information Officer | Sell | 13,020 | $95.73 | $1.2M |
| Jan 21, 2026 | Monroe Terilyn J.Chief People Officer | Sell | 3,619 | $113.48 | $411K |
| Jan 21, 2026 | Monroe Terilyn J.Chief People Officer | Sell | 3,249 | $115.70 | $376K |
| Jan 21, 2026 | Monroe Terilyn J.Chief People Officer | Sell | 1,703 | $112.34 | $191K |
| Jan 7, 2026 | Monroe Terilyn J.Chief People Officer | Sell | 6,311 | $111.75 | $705K |
| Jan 7, 2026 | Monroe Terilyn J.Chief People Officer | Sell | 3,632 | $112.62 | $409K |
| Jan 7, 2026 | Monroe Terilyn J.Chief People Officer | Sell | 88 | $113.44 | $10K |
| Dec 17, 2025 | Tariq MusaDirector | Sell | 116 | $101.46 | $12K |
| Dec 15, 2025 | Eltoukhy HelmyCo-Chief Executive Officer | Sell | 83,945 | $103.80 | $8.7M |
| Dec 15, 2025 | Eltoukhy HelmyCo-Chief Executive Officer | Sell | 6,620 | $104.02 | $689K |
| Dec 15, 2025 | Chudova DaryaChief Technology Officer | Sell | 5,451 | $104.04 | $567K |
| Dec 8, 2025 | Talasaz AmiraliCo-Chief Executive Officer | Sell | 30,760 | $105.34 | $3.2M |
| Dec 8, 2025 | Talasaz AmiraliCo-Chief Executive Officer | Sell | 15,000 | $104.21 | $1.6M |
| Dec 8, 2025 | Chudova DaryaChief Technology Officer | Sell | 13,664 | $105.04 | $1.4M |
| Dec 8, 2025 | Chudova DaryaChief Technology Officer | Sell | 9,271 | $106.00 | $983K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
⚡ Elevated coverageCoverage (30d): 2 reputable articles · skews – neutral.
Investor's Business DailyStock Market Today: Nasdaq Undercuts Support In AI Sell-Off; Guardant Health, Fortinet, Ezcorp In Focus6d agoInvestor's Business DailyHere's Why This Colon Cancer Testing Biotech Is A Mutual Fund Favorite26d agoInvestor's Business DailyGuardant Health Leaps On A Major Win In Cancer Detection; Will Shares Break Out?1mo ago
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance